Abbvie Inc (NYSE:ABBV)
| 141.96 Delayed Data As of Oct 04 |  -0.03 / -0.02%Today’s Change | 106.86 Today|||52-Week Range 175.91 | +4.84% Year-to-Date |
Latest ABBV News | Press Releases
| Here is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock Oct 04 / Zacks.com - Paid Partner Content | Got $2,000? Buy These 2 Bear Market-Beating Growth Stocks Oct 02 / MotleyFool.com - Paid Partner Content |
| Reata Pharma (RETA) is Striving Hard Despite Pipeline Setbacks Oct 04 / Zacks.com - Paid Partner Content | Here's Why This Dividend King Is a Buy Oct 01 / MotleyFool.com - Paid Partner Content |
| PARK NATIONAL CORP /OH/ Buys 4, Sells 1 in 3rd Quarter Oct 03 / GuruFocus News - Paid Partner Content | 3 Safe Stocks You'll Want to Have Exposure to in 2022 Sep 30 / StockNews.com - Paid Partner Content |
| Can AbbVie's (ABBV) New Drugs Make up for Lost Humira Sales? Oct 03 / Zacks.com - Paid Partner Content | Where Will AbbVie Be in 3 Years? Sep 30 / MotleyFool.com - Paid Partner Content |
| Bear Market Bargains: 3 Dividend Stocks to Buy Now Oct 03 / MotleyFool.com - Paid Partner Content | Where to Invest $10,000 Right Now Sep 28 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 141.99 |
| Today’s open | 139.48 |
| Day’s range | 137.82 - 142.71 |
| Volume | 15 |
| Average volume (3 months) | 5,819,411 |
| Market cap | $237.3B |
Data as of 4:00pm ET, 10/04/2022
Growth & Valuation
| Earnings growth (last year) | +137.07% |
| Earnings growth (this year) | +9.13% |
| Earnings growth (next 5 years) | -2.00% |
| Revenue growth (last year) | +22.69% |
| P/E ratio | 20.1 |
| Price/Sales | 4.28 |
| Price/Book | 15.40 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PFEPfizer | +0.32 | +0.72% |
| MRKMerck | +0.01 | +0.01% |
| LLYEli Lilly and Co | +0.20 | +0.06% |
| NVONovo Nordisk | -0.01 | -0.01% |
Data as of 4:00pm ET, 10/04/2022
Financials
| Next reporting date | November 4, 2022 |
| EPS forecast (this quarter) | $3.60 |
| Annual revenue (last year) | $56.2B |
| Annual profit (last year) | $11.5B |
| Net profit margin | 20.41% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters North Chicago, Illinois |
Forecasts
